| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 673187 | - | 0.0385613993886001 | -0.12182961 |
| NSC 67586 | 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, | 0.0385613993886001 | 0.13768983 |
| NSC 687522 | Null | 0.0385613993886001 | 0.049447469 |
| NSC 692579 | Null | 0.0385613993886001 | -0.12406852 |
| NSC 701314 | 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- | 0.0385613993886001 | -0.13818341 |
| NSC 703544 | Null | 0.0385613993886001 | 0.0098294477 |
| NSC 708423 | Null | 0.0385613993886001 | -0.14521219 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0385613993886001 | -0.097954528 |
| NSC 733504 | Everolimus | 0.0385613993886001 | 0.075833812 |
| NSC 736041 | 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne | 0.0385613993886001 | -0.0059028742 |